PubMed · 5011783
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1972. A nuclear medicine quality control program.. https://pubmed.ncbi.nlm.nih.gov/5011783/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
1. Glial cells are known to play a role in regulating the microenvironment of the nervous system. While earlier considerations of glial function assumed a passive, static physiology for these cells, this is not likely to be the case. In this study, we begin to examine how the physiology of Müller glial cells changes in response to molecules in the microenvironment. 2. Perforated-path recordings and intracellular calcium measurements were performed on human retinal Müller cells in vitro. 3. Analysis of whole-cell currents revealed that the human Müller glial cells have an inwardly rectifying K+ current (IK(IR) which is active near the resting membrane potential. This IK(IR) is significantly inhibited when the Müller cell is exposed to thrombin, a molecule that is likely to enter the retina with a breakdown of the blood-retinal barrier and may be endogenous to the nervous system. 4. A variety of experiments point to a role for Ca2+ as a second messenger mediating the inhibitory effect of thrombin on the IK(IR) of Müller cells. Specifically, thrombin evokes an increase in intracellular [Ca2+] in the Müller cells; the Ca2+ chelator BAPTA blocks the effects of thrombin on both the inhibition of IK(IR) and the rise in intracellular [Ca2+]; exposure to ionomycin, a calcium ionophore, induces a reduction in the IK(IR) of Müller cells. 5. A thrombin- induced inhibition in the IK(IR) of Müller cells is likely to have significant functional consequences for the retina since these ion channels are involved in K+ homeostasis. 6. Our experiments support the idea that the physiology of Müller glial cells is dynamic and can be markedly affected by molecules in the microenvironment.
Whole-cell Ca2+ channel currents were recorded in human neuroblastoma (SH-SY5Y) cells, using the perforated-patch technique with 10 mM Ba2+ as charge carrier. Neuropeptide Y (NPY; 10 nM to 1 microM) caused concentration-dependent inhibition of Ca2+ channel currents which were associated with a slowing in current activation kinetics. [Ala31]NPY, a residue 31 L-alanine substituted analogue of NPY, also inhibited Ca2+ channel currents and caused slowing of activation kinetics, but with approximately 6-fold lower potency. In the presence of 100 nM [Ala31]NPY (which itself had little or no effect on currents), the actions of NPY were similar in magnitude to its effects in the absence of the analogue. Our results suggest that substitution of isoleucine for alanine at residue 31 results in a NPY analogue which is a full agonist but with lower affinity for Y2 receptors.
Replacement of Ca2+ with Ba2+ in HEPES-buffered saline stimulated [3H]noradrenalin release in the human neuroblastoma clone SH-SY5Y by up to 20% of the cell content in the absence of other secretory stimuli. The Ba(2+)-evoked release was inhibited by 85% by 3 microM tetrodotoxin and 95% by 5 microM nifedipine. Ba2+ also increased the potency of K(+)-evoked release of [3H]noradrenalin, as maximal release was observed with 60 mM K+ compared with the 100 mM K+ necessary to achieve maximal release in the presence of Ca2+. In contrast, replacing Ca2+ with Ba2+ had little effect on carbachol- and bradykinin-evoked release of [3H]noradrenalin. No evidence was obtained from studies on changes in [Ca2+]i (in response to 100 microM carbachol) using fura-2 that Ba2+ could enter intracellular stores in SH-SY5Y cells. Whole-cell patch-clamp studies showed that Ba2+ depolarizes SH-SY5Y cells as well as enhancing inward Ca2+ channel currents and shifting their voltage dependence to more negative values. These results are discussed in terms of the hypothesis that Ba2+ blocks K+ channels, leading to depolarization followed by opening of voltage-sensitive Na+ channels. This in turn opens voltage-sensitive L-type Ca2+ channels, which are coupled to the release of [3H]noradrenalin in SH-SY5Y cells.